Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Vir Biotechnology, Inc. (VIR)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-05-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Dec-05-21
   10-Q10-Q8-K10-Q10-Q10-Q10-K8-K
Net income   -143.7 1,142.71,077.81,216.1528.6 
Depreciation and amortization   [+]   6.15.9 5.3 
Stock-based compensation      52.4   
Deferred taxes        15.2 
Change in working capital   [+]   545.8674.0 150.5 
Other operating activities     -126.3-413.2 -747.2 
Cash from operations     1,635.81,412.1 -47.6 
   
Capital expenditures   [+]   -4.4-17.4 21.8 
Other cash from investing     -1,413.6-664.1 -162.6 
Cash from investing     -1,417.9-681.4 -140.8 
   
Option exercises   5.4 7.010.87.813.1 
Other cash from financing     45.550.8 113.4 
Cash from financing     38.440.1 100.3 
   
Free cash flow     1,631.41,394.7 -25.8 
        Per share (diluted)     $12.19$10.44 ($0.19) 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy